Sotalol enhances the anticonvulsant action of valproate and diphenylhydantoin in the mouse maximal electroshock model

Ponnusamy, 2012, Comparison of heart rate variability parameters during complex partial seizures and psychogenic nonepileptic seizures, Epilepsia, 53, 1314, 10.1111/j.1528-1167.2012.03518.x Massey, 2014, Mechanisms of sudden unexpected death in epilepsy: the pathway to prevention, Nat Rev Neurol, 10, 271, 10.1038/nrneurol.2014.64 Little, 2012, β Adrenergic blockade prevents cardiac dysfunction following status epilepticus in rats, Epilepsy Res, 99, 233, 10.1016/j.eplepsyres.2011.12.003 Nei, 2004, EEG and ECG in sudden unexplained death in epilepsy, Epilepsia, 45, 338, 10.1111/j.0013-9580.2004.05503.x Dlouhy, 2015, Breathing inhibited when seizures spread to the amygdala and upon amygdala stimulation, J Neurosci, 35, 10281, 10.1523/JNEUROSCI.0888-15.2015 Beach, 1995, Reactive microglia in hippocampal sclerosis associated with human temporal lobe epilepsy, Neurosci Lett, 191, 27, 10.1016/0304-3940(94)11548-1 Eyo, 2014, Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus, J Neurosci, 34, 10528, 10.1523/JNEUROSCI.0416-14.2014 Vinet, 2012, Neuroprotective function for ramified microglia in hippocampal excitotoxicity, J Neuroinflamm, 9, 27, 10.1186/1742-2094-9-27 Szalay, 2016, Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke, Nat Commun, 7, 11499, 10.1038/ncomms11499 Qin, 2007, Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration, Glia, 55, 453, 10.1002/glia.20467 Mueller, 2014, Evidence for brainstem network disruption in temporal lobe epilepsy and sudden unexplained death in epilepsy, Neuroimage Clin, 5, 208, 10.1016/j.nicl.2014.06.010 Anderson, 1999, An important new antiarrhythmic, Am Heart J, 137, 388, 10.1016/S0002-8703(99)70484-9 Patterson, 1984, Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol, J Pharm Exp Ther, 230, 519 Zamorano-León, 2012, KCNH2 gene mutation: a potential link between epilepsy and long QT-2 syndrome, J Neurogenet, 26, 382, 10.3109/01677063.2012.674993 Khanna, 1989, Effect of beta-adrenoceptor antagonists and some related drugs on maximal electroshock seizures in mice, Indian J Exp Biol, 27, 128 Luchowska, 2002, Propranolol and metoprolol enhance the anticonvulsant action of valproate and diazepam against maximal electroshock, Pharmacol Biochem Behav, 71, 223, 10.1016/S0091-3057(01)00654-2 Shafaroodi, 2016, The interaction between morphine and propranolol in chemical and electrical seizure models of mice, Neurol Res, 38, 166, 10.1080/01616412.2015.1136779 Nakamura, 2008, Propranolol increases the threshold for lidocaine-induced convulsions in awake rats: a direct effect on the brain, Anesth Analg, 106, 1450, 10.1213/ane.0b013e31816ba49d Tkatchenko, 1987, Influence of beta adrenergic blockers and their combinations with anticholinergic drugs on epileptiform activity in rabbit hippocampus, Biomed Biochim Acta, 46, 429 Amabeoku, 1994, Strychnine-induced seizures in mice: the role of noradrenaline, Prog Neuropsychopharmacol Biol Psychiatry, 18, 753, 10.1016/0278-5846(94)90082-5 Pericic, 2000, Beta-1 adrenoceptor antagonists potentiate the anticonvulsive effect of swim stress in mice, Pharmacol Biochem Behav, 67, 507, 10.1016/S0091-3057(00)00385-3 Paul, 1989, The effect of beta-adrenoceptor antagonists alone and in combination with a GABA-elevating agent on isoniazid-induced convulsions in rats, Indian J Physiol Pharmacol, 33, 175 Lints, 1985, A possible role for beta-adrenergic receptors in the expression of audiogenic seizures, Pharmacol Biochem Behav, 22, 711, 10.1016/0091-3057(85)90518-0 De Sarro, 2002, Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice, Eur J Pharmacol, 442, 205, 10.1016/S0014-2999(02)01536-4 Lathers, 1989, Anticonvulsant and antiarrhythmic actions of the beta blocking agent timolol, Epilepsy Res, 4, 42, 10.1016/0920-1211(89)90057-0 Borowicz, 2014, Antiarrhythmic drugs and epilepsy, Pharmacol Rep, 66, 545, 10.1016/j.pharep.2014.03.009 Castel-Branco, 2009, The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drug, Methods Find Exp Clin Pharmacol, 31, 101, 10.1358/mf.2009.31.2.1338414 Borowicz, 2007, Acute and chronic treatment with mianserin differentially affects the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model, Psychopharmacology (Berl.), 195, 167, 10.1007/s00213-007-0878-9 Litchfield, 1949, A simplified method of evaluating dose-effect experiments, J Pharmacol Exp Ther, 96, 99 Boissier, 1960, Une nouvelle methode simple pour explorer l’action tranquilisante: le test de la cheminee, Med Exp (Basel), 3, 81, 10.1159/000134913 Lafuente-Lafuente, 2015, Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation, Cochrane Database Syst Rev, 3, CD005049 Goel, 2011, Influence of carvedilol on anticonvulsant effect of gabapentin, Acta Neurol Belg, 111, 296 Chugh, 1991, Diazepam-atenolol combination antagonizes aminophylline-induced convulsions and lethality in mice, Eur J Pharmacol, 199, 135, 10.1016/0014-2999(91)90650-F Wada, 1999, Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats, Neurosci Lett, 267, 61, 10.1016/S0304-3940(99)00321-3 Raju, 1998, Effect of propranolol and nifedipine on maximal electroshock-induced seizures in mice: individually and in combination, Pharmacol Res, 38, 449, 10.1006/phrs.1998.0390 de Oliveira, 1994, Propranolol action in chronically unstable generalized epilepsy, Am J Ther, 1, 38, 10.1097/00045391-199406000-00007 Mayer, 1995, Propranolol in startle induced epileptic seizures, J Neurol Neurosurg Psychiatry, 58, 382, 10.1136/jnnp.58.3.382 Banach, 2016, Propafenone enhances the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock model, Pharmacol Rep, 68, 555, 10.1016/j.pharep.2016.01.002 Reagan-Shaw, 2007, Dose translation from animal to human studies revisited, FASEB J, 22, 659, 10.1096/fj.07-9574LSF